- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
12:00 pm – 1:00 pm HST | 3:00 pm – 4:00 pm PDT
This is a virtual event for members in Hawaii, California, Nevada, Idaho, Oregon, and Washington.
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

Leon Ravin, MD
Psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada
More

Laura Brennan, PhD (OPDC)
Medical Science Liaison
Leon Ravin, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Laura Brennan, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)